Jaye Viner
First SEC filing: Aug. 28, 2013 · Latest: Aug. 28, 2013
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2015 | CRIS | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2015 | CRIS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRIS | A | 120,000 | · | · | 180,000 Direct | +200.00% | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRIS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRIS | A | 120,000 | · | · | 180,000 Direct | +200.00% | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2014 | CRIS | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 27, 2013 | CRIS | A | 97,320 | $4.11 | $399,985 | 97,320 Direct | · | Acquired | -100.0% (price as of 2026-10-02) |
| Aug. 27, 2013 | CRIS | A | 277,680 | $4.11 | $1,141,265 | 277,680 Direct | · | Acquired | -100.0% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 27, 2015 | CRIS | Employee stock option (right to buy) | Common stock | $2.39 | Feb. 9, 2025 | 80,000 | Acquired |
| Jan. 26, 2015 | CRIS | Employee stock option (right to buy) | Common stock | $1.94 | Jan. 26, 2025 | 100,000 | Acquired |
| Feb. 18, 2014 | CRIS | Nonqualified Stock Option (right to buy) | Common Stock | $3.09 | Feb. 18, 2024 | 120,000 | Acquired |
| Feb. 18, 2014 | CRIS | Employee Stock Option (right to buy) | Common stock | $3.09 | Feb. 18, 2024 | 60,000 | Acquired |
| Feb. 18, 2014 | CRIS | Nonqualified Stock Option (right to buy) | Common Stock | $3.09 | Feb. 18, 2024 | 120,000 | Acquired |
| Feb. 18, 2014 | CRIS | Employee Stock Option (right to buy) | Common stock | $3.09 | Feb. 18, 2024 | 60,000 | Acquired |
| Aug. 27, 2013 | CRIS | Nonqualified Stock Option (right to buy) | Common Stock | $4.11 | Aug. 27, 2023 | 97,320 | Acquired |
| Aug. 27, 2013 | CRIS | Qualified Stock Option (right to buy) | Common stock | $4.11 | Aug. 27, 2023 | 277,680 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | · | · | · | · | · | · | · | · |
| 2014 | $409,731,142,788 | · | · | · | $146,991,111,464 | · | $104,005,712 | $8,365,191,295,339 |
| 2013 | $142,788 | · | · | · | $111,464 | · | $5,712 | $1,295,339 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.